An Oct. 7 meeting was part of the FDA's review process of pending applications for IQOS ILUMA. "We encourage the FDA to continue efforts to establish a timely scientific review process for smoke-free ...
Detailed price information for Philip Morris International Inc (PM-N) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback